查看完整行情页>>
|
货币单位:美元(USD)
FibroGen, Inc. (fgen)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| State Street Global Advisors |
937694 |
1.01% |
-39465 |
-4.04% |
2022-05-31
|
| BlackRock Fund Advisors |
3740643 |
4.01% |
-147277 |
-3.79% |
2022-05-31
|
| State Street Corporation |
4927781 |
5.28% |
420828 |
9.34% |
2022-03-31
|
| Federated MDTA LLC |
5295035 |
5.68% |
3412614 |
181.29% |
2022-05-31
|
| Point72 Asset Management, L.P. |
5832161 |
6.25% |
2099567 |
56.25% |
2022-03-31
|
| BlackRock Inc |
6645542 |
7.12% |
9763 |
0.15% |
2021-12-31
|
| SSGA Funds Management Inc |
8275105 |
8.87% |
3186477 |
62.62% |
2022-05-31
|
| Vanguard Group Inc |
9349957 |
10.02% |
313769 |
3.47% |
2022-03-31
|
| PRIMECAP Management Company |
13317857 |
14.27% |
328734 |
2.53% |
2022-03-31
|
| First Trust Advisors L.P. |
3478987 |
3.73% |
-1838626 |
-34.58% |
2022-03-31
|
| Vanguard Investments Australia Ltd |
2477554 |
2.66% |
-563 |
-0.02% |
2022-05-31
|
| Soleus Capital Management, L.P. |
1064356 |
1.14% |
-486141 |
-31.35% |
2022-03-31
|
| BNY Mellon Investment Funds VII, Inc. |
1264426 |
1.36% |
-873749 |
-40.86% |
2022-05-31
|
| Northern Trust Investments Inc |
1302299 |
1.40% |
-85374 |
-6.15% |
2022-05-31
|
| Jacobs Levy Equity Management, Inc. |
1466807 |
1.57% |
80387 |
5.80% |
2022-03-31
|
| Geode Capital Management, LLC |
1585564 |
1.70% |
-40036 |
-2.46% |
2022-03-31
|
| Schroder Investment Management Group |
1607215 |
1.72% |
293256 |
22.32% |
2022-03-31
|
| Fidelity Management & Research Company LLC |
1791018 |
1.92% |
-3312803 |
-64.91% |
2022-05-31
|
| Federated Hermes Inc |
2395883 |
2.57% |
1094403 |
84.09% |
2022-03-31
|
| Two Sigma Investments LLC |
1029190 |
1.10% |
-306615 |
-22.95% |
2021-12-31
|
| BNY Mellon Investment Adviser, Inc. |
1264426 |
1.36% |
-873749 |
-40.86% |
2022-04-30
|
| Goldman Sachs Group Inc |
1009676 |
1.09% |
106654 |
11.81% |
2021-12-31
|
| Fidelity Institutional Asset Management |
1170782 |
1.26% |
-153777 |
-11.61% |
2022-02-28
|
| Two Sigma Advisers, LLC |
1009400 |
1.09% |
640800 |
173.85% |
2021-09-30
|
| Farallon Capital Management, L.L.C. |
919117 |
0.99% |
-527095 |
-36.45% |
2021-12-31
|
| JPMorgan Chase & Co |
1274966 |
1.38% |
-973267 |
-43.29% |
2021-09-30
|
| Bank of New York Mellon Corp |
2135418 |
2.30% |
-196480 |
-8.43% |
2021-06-30
|
| FMR Inc |
3632508 |
3.92% |
-2086673 |
-36.49% |
2021-06-30
|
| Hillhouse Capital Advisors, Ltd. |
3955787 |
4.27% |
-- |
-- |
2021-06-30
|
| Dreyfus Corp |
1248883 |
1.35% |
-15543 |
-1.23% |
2021-06-30
|
| HHG PLC |
1224474 |
1.32% |
-2059793 |
-62.72% |
2021-06-30
|
| J.P. Morgan Investment Management, Inc. |
1094838 |
1.18% |
-92144 |
-7.76% |
2021-10-31
|
| Fidelity SelectCo, LLC |
2414487 |
2.61% |
-4563938 |
-65.40% |
2021-08-31
|
| T. Rowe Price Associates, Inc. |
1898067 |
2.05% |
-1729330 |
-47.67% |
2021-03-31
|
| Fidelity Management and Research Company |
5147026 |
5.56% |
-183482 |
-3.44% |
2021-03-31
|
| Janus Henderson Investors |
1730070 |
1.88% |
-15703 |
-0.90% |
2021-07-31
|
| Janus Capital Management LLC |
2782654 |
3.02% |
-90213 |
-3.14% |
2021-07-31
|
| JPMorgan Chase & Co |
1776999 |
1.95% |
95655 |
5.69% |
2020-06-30
|
| Fidelity Management & Research Company LLC |
6006659 |
6.60% |
-1393161 |
-18.83% |
2020-11-30
|
| Fidelity Management & Research Company |
6611314 |
7.61% |
-719870 |
-9.82% |
2020-05-31
|
| EcoR1 Capital, LLC |
1492221 |
1.72% |
198414 |
15.34% |
2019-12-31
|
| Northern Trust Corp |
1032946 |
1.19% |
37867 |
3.81% |
2019-09-30
|
| Northern Trust Investments N A |
1032946 |
1.19% |
37867 |
3.81% |
2019-09-30
|
| Adage Capital Partners Gp LLC |
1500000 |
1.73% |
-200000 |
-11.76% |
2019-09-30
|
| Eagle Asset Management, Inc. |
947195 |
1.09% |
2509 |
0.27% |
2019-03-31
|
| BlackRock Asset Management Canada Ltd |
1755037 |
2.04% |
-489 |
-0.03% |
2019-05-31
|
| Hillhouse Capital Management, Ltd. |
2686196 |
3.14% |
-- |
-- |
2018-09-30
|
| BlackRock Institutional Trust Company NA |
2190571 |
2.58% |
-33284 |
-1.50% |
2018-06-30
|
| State Street Corp |
2475018 |
2.94% |
-246208 |
-9.05% |
2018-06-30
|
| Credit Suisse First Boston (CSFB) |
671241 |
0.80% |
-198785 |
-22.85% |
2018-06-30
|
| Lord, Abbett & Co LLC |
619500 |
0.74% |
40211 |
6.94% |
2018-06-30
|
| Goldman, Sachs & Co. |
585726 |
0.70% |
117332 |
25.05% |
2018-06-30
|
| Jennison Associates LLC |
526343 |
0.63% |
201289 |
61.92% |
2018-06-30
|
| Charles Schwab Investment Management Inc |
469708 |
0.56% |
81074 |
20.86% |
2018-06-30
|
| Pinnacle Associates Inc |
534433 |
0.64% |
-23790 |
-4.26% |
2018-03-31
|
| Voya Investments, LLC |
374635 |
0.45% |
10746 |
2.95% |
2018-06-30
|
| J P Morgan Asset Management (UK) Ltd |
474158 |
0.57% |
-87609 |
-15.60% |
2018-03-31
|
| NORGES BANK |
665018 |
0.81% |
268743 |
67.82% |
2017-12-31
|
| ING Investment Management LLC |
601841 |
0.74% |
574802 |
2125.83% |
2017-09-30
|
| Opaleye Management Inc |
360000 |
0.44% |
-- |
-- |
2017-09-30
|
| Teachers Advisors Inc |
521614 |
0.64% |
-14665 |
-2.73% |
2017-09-30
|
| Janus Capital International Ltd |
350756 |
0.43% |
-2583 |
-0.73% |
2017-09-30
|
| J.P. Morgan Investment Management Inc |
355057 |
0.43% |
16060 |
4.74% |
2017-09-30
|
| OppenheimerFunds Inc |
356200 |
0.44% |
-206 |
-0.06% |
2017-09-30
|
| PointState Capital LP |
400000 |
0.63% |
50000 |
14.29% |
2016-09-30
|
| Candriam Luxembourg |
460000 |
0.73% |
-21000 |
-4.37% |
2016-12-31
|
| Omega Fund Management LLC |
822175 |
1.30% |
-- |
-- |
2016-09-30
|
| Waddell & Reed Investment Management Co |
1784482 |
2.83% |
-247030 |
-12.16% |
2016-09-30
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Fidelity |
436846 |
0.47% |
17419 |
4.15% |
2022-04-30
|
| PrimeCap Odyssey Growth Fund |
1888060 |
2.02% |
-92600 |
-4.68% |
2022-03-31
|
| iShares Russell 2000 ETF |
1907308 |
2.04% |
3240 |
0.17% |
2022-05-31
|
| Vanguard Small Cap Index |
2088056 |
2.24% |
-5609 |
-0.27% |
2022-05-31
|
| Vanguard Total Stock Market Index Fund |
2464850 |
2.64% |
-- |
-- |
2022-05-31
|
| SPDR |
3405617 |
3.65% |
115115 |
3.50% |
2022-05-31
|
| First Trust NYSE Arca Biotech Fund |
4076365 |
4.37% |
-- |
-- |
2022-05-31
|
| PrimeCap Odyssey Aggressive Growth Fund |
4305791 |
4.62% |
800 |
0.02% |
2022-03-31
|
| Vanguard Capital Opportunity Fund |
4435971 |
4.75% |
412600 |
10.26% |
2022-03-31
|
| Vanguard Small Cap Growth Index Fund |
1281652 |
1.37% |
12669 |
1.00% |
2022-05-31
|
| Federated Hermes MDT Small Cap Core Fund |
1228696 |
1.32% |
605301 |
97.10% |
2022-03-31
|
| Vanguard U.S. Opportunities Fund |
483871 |
0.52% |
-- |
-- |
2022-04-30
|
| iShares Biotechnology ETF |
646629 |
0.69% |
-7154 |
-1.09% |
2022-05-31
|
| iShares Russell 2000 Growth ETF |
680981 |
0.73% |
-785 |
-0.12% |
2022-05-31
|
| Vanguard Explorer Fund |
711913 |
0.76% |
165954 |
30.40% |
2022-03-31
|
| Federated Hermes MDT SCG Institutional |
959430 |
1.03% |
958982 |
214058.48% |
2022-03-31
|
| Federated Hermes MDT Small Cap Growth Fd |
959430 |
1.03% |
331842 |
52.88% |
2022-03-31
|
| Vanguard Extended Market Index Fund |
1144282 |
1.23% |
1336 |
0.12% |
2022-05-31
|
| Federated Hermes MDT SCC Institutional |
1228696 |
1.32% |
605301 |
97.10% |
2022-03-31
|
| State Street Russell Small/Mid Cap |
435049 |
0.47% |
7400 |
1.73% |
2022-04-30
|
| Invesco Dynamic Biotech & Genome ETF |
413514 |
0.44% |
-- |
-- |
2022-04-28
|
| FIAM Small Cap Core |
572531 |
0.62% |
-- |
-- |
2021-09-30
|
| FIAM Small Cap Core Commingled Pool |
572531 |
0.62% |
-- |
-- |
2021-09-30
|
| Candriam Eqs L Biotechnology |
389324 |
0.42% |
134828 |
52.98% |
2021-11-30
|
| Schwab US Small-Cap ETF |
344234 |
0.37% |
204 |
0.06% |
2021-12-31
|
| Danske Invest Bioteknologi Indeks KL |
344110 |
0.37% |
-5300 |
-1.52% |
2021-11-30
|
| Direxion Daily S&P Biotech Bull 3X Shrs |
532800 |
0.57% |
21952 |
4.30% |
2021-11-30
|
| JPMorgan Small Cap Growth Fund |
487799 |
0.53% |
-405317 |
-45.38% |
2021-09-30
|
| Janus Henderson Global Life Science |
391946 |
0.42% |
-4527 |
-1.14% |
2021-06-30
|
| Janus Henderson Global Life Sciences Fd |
391946 |
0.42% |
-4527 |
-1.14% |
2021-06-30
|
| BNY Mellon Sm/Md Cp Gr Fd |
1248883 |
1.35% |
-- |
-- |
2021-08-31
|
| JPM Global Healthcare Fund |
394154 |
0.43% |
-- |
-- |
2021-08-31
|
| Fidelity Advisor |
606901 |
0.66% |
-- |
-- |
2021-06-30
|
| Janus Henderson Triton Fund |
1333597 |
1.45% |
-- |
-- |
2021-03-31
|
| Janus Henderson US SMID Cap Growth |
1333597 |
1.45% |
-- |
-- |
2021-03-31
|
| iShares Nasdaq Biotechnology ETF |
772511 |
0.84% |
-3480 |
-0.45% |
2021-05-28
|
| Janus Henderson US Small Cap Growth |
628104 |
0.68% |
-- |
-- |
2020-12-31
|
| Janus Henderson Venture Fund |
628104 |
0.68% |
-- |
-- |
2020-12-31
|
| T. Rowe Price New Horizons Fund |
1026891 |
1.12% |
-60800 |
-5.59% |
2020-12-31
|
| T. Rowe Price Health Sciences Fund |
1053397 |
1.14% |
-130296 |
-11.01% |
2020-12-31
|
| Carillon Eagle Small Cap Growth Fund |
708315 |
0.82% |
-- |
-- |
2019-03-31
|
| Fidelity Contrafund Commingled Pool |
570839 |
0.66% |
67690 |
13.45% |
2019-04-30
|
| iShares US Small Cap ETF (CAD-Hedged) |
1550380 |
1.80% |
-2601 |
-0.17% |
2019-05-30
|
| DWS Biotech |
701640 |
0.81% |
526154 |
299.83% |
2019-04-30
|
| Vanguard Small Cap Index Fund |
2001416 |
2.32% |
12610 |
0.63% |
2019-04-30
|
| T. Rowe Price QM US Small-Cap Gr Eq Fd |
366700 |
0.43% |
2800 |
0.77% |
2018-09-30
|
| Lord Abbett Developing Growth Fund |
366728 |
0.43% |
13 |
-- |
2018-10-31
|
| Vanguard Total Stock Mkt Idx |
1885477 |
2.24% |
1840 |
0.10% |
2018-07-31
|
| Vanguard Small Cap Growth Index Inv |
1079901 |
1.28% |
15948 |
1.50% |
2018-07-31
|
| First Trust NYSE Arca Biotech ETF |
1141905 |
1.32% |
-- |
-- |
2018-09-13
|
| Vanguard Extended Market Idx Inv |
1026541 |
1.22% |
6888 |
0.68% |
2018-07-31
|
| iShares Nasdaq Biotechnology |
948421 |
1.10% |
-1806 |
-0.19% |
2018-09-12
|
| T. Rowe Price Health Sciences |
828136 |
0.98% |
115799 |
16.26% |
2018-06-30
|
| Eagle Small Cap Growth A |
708315 |
0.84% |
107349 |
17.86% |
2018-06-30
|
| iShares Russell 2000 Growth |
721997 |
0.83% |
-696 |
-0.10% |
2018-09-12
|
| JPMorgan Small Cap Growth A |
347594 |
0.41% |
26076 |
8.11% |
2018-07-31
|
| Fidelity Spartan |
353603 |
0.42% |
-- |
-- |
2018-07-31
|
| T. Rowe Price QM US Small-Cap Growth Eq |
363900 |
0.43% |
84800 |
30.38% |
2018-06-30
|
| Lord Abbett Developing Growth A |
366226 |
0.43% |
-4122 |
-1.11% |
2018-07-31
|
| Janus Global Life Sciences D |
415967 |
0.49% |
-231928 |
-35.80% |
2018-06-30
|
| T. Rowe Price New Horizons |
600416 |
0.71% |
114600 |
23.59% |
2018-06-30
|
| Oppenheimer International Small-Mid Co A |
351750 |
0.42% |
-- |
-- |
2018-06-30
|
| Janus Venture D |
315627 |
0.38% |
-- |
-- |
2018-03-31
|
| Vanguard Market Neutral I |
356326 |
0.44% |
-- |
-- |
2017-09-30
|
| TIAA-CREF Small-Cap Equity Instl |
345926 |
0.42% |
-- |
-- |
2017-10-31
|
| Vanguard Explorer Inv |
217500 |
0.34% |
80500 |
58.76% |
2016-09-30
|
| CREF Stock R1 |
231960 |
0.37% |
-5002 |
-2.11% |
2016-12-31
|
| JPM Global Healthcare |
876822 |
1.40% |
-- |
-- |
2015-09-30
|
| iShares Russell 2000 (AU) |
759481 |
1.40% |
-960 |
-0.10% |
2015-11-19
|
| Waddell & Reed Advisor Science And Techn |
704747 |
1.10% |
-- |
-- |
2015-09-30
|
| Franklin Biotechnology Discovery Fund |
451308 |
0.70% |
-- |
-- |
2015-09-30
|
| Franklin Biotechnology Discovery |
400000 |
0.70% |
-- |
-- |
2015-07-31
|
| Janus Global Life Sciences Fund |
365211 |
0.60% |
36624 |
11.20% |
2015-09-30
|
| Fidelity® Select Biotechnology Portfolio |
363239 |
0.60% |
-- |
-- |
2015-09-30
|
| AZ InvestEd Ivy Science & Tech Fund |
1187299 |
1.90% |
-- |
-- |
2015-09-30
|
